Adults who have multiple myeloma, a type of cancer that affects certain white blood cells, may receive a medication called Pomalyst® (pomalidomide). This medication comes as a capsule that is taken once daily for 21 days, followed by a 7-day break in treatment. This 28-day cycle is repeated until the cancer progresses or serious side effects occur. The specific dosage you receive will depend on how well you tolerate the medicine and other factors.
Most people who take Pomalyst will experience some type of side effect. Some of the most common problems include nausea, constipation, and shortness of breath. Because this chemotherapy drug is not suitable for everyone, it's important to review Pomalyst's safety information with your healthcare provider before starting treatment. For example, make sure your healthcare provider is aware of any other health issues you may have, such as kidney disease, liver disease, or any allergies.
(Click Pomalyst for more information on this chemotherapy drug, including how it works, dosing guidelines, and more.)
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed March 9, 2013.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click